Acuren Corporation Announces Approval for Listing on the NYSE American Exchange
Acuren Corporation (the “Company” or “Acuren”) (OTCQX: TICA), a leading provider of asset integrity services, has officially announced that its common stock has been approved for listing on the NYSE American stock exchange. This marks a significant milestone in the company’s journey, highlighting its growth and positioning within the industry.
According to the announcement, Acuren’s common stock will begin trading on the NYSE American under its new ticker symbol, “TIC,” starting February 18, 2025. Until then, the company’s stock will continue to trade on the OTCQX, with its final day of trading on that platform set for February 14, 2025. Shareholders and investors are not required to take any action ahead of this transition, as all trading activity will be seamlessly migrated to the NYSE American.
Talman Pizzey, Chief Executive Officer of Acuren Corporation, expressed his enthusiasm regarding the company’s advancement to a new exchange, stating, “We are delighted to announce our listing on the NYSE American exchange. This represents a critical step in our strategic vision for the future, providing Acuren with a broader platform to engage with institutional and retail investors. Our entry onto this prestigious exchange underscores our commitment to operational excellence, reinforces our leadership position in the asset integrity sector, and sets the stage for sustained growth in the Testing, Inspection, and Certification (TIC) industry.”
Acuren’s leadership believes that this move will enhance visibility and market confidence in the company, making it an attractive opportunity for a broader range of investors. The company has maintained a steady trajectory of growth in recent years, leveraging its expertise and industry presence to expand its footprint across North America.
Robert Franklin, Co-Chairman of Acuren, echoed this sentiment, emphasizing the long-term benefits of the listing. “Our listing on the NYSE American marks another milestone toward our ultimate goal of trading on the New York Stock Exchange (NYSE). This move is strategically important as it allows us to further extend our reach within the investment community, increase trading liquidity, and elevate our corporate profile. We remain steadfast in our commitment to generating long-term value for our stakeholders while continuing to advance Acuren’s market presence in the coming years.”
Strategic Importance of NYSE American Listing
The approval for listing on the NYSE American comes at a crucial time for Acuren as it continues to strengthen its operations and expand its market share. The NYSE American exchange is widely recognized as a premier venue for smaller-cap companies seeking to grow their investor base and increase stock liquidity. For Acuren, the move from OTCQX to NYSE American represents a natural progression that aligns with its corporate goals.
Benefits of the NYSE American Listing for Acuren Corporation
- Increased Investor Reach: Being listed on the NYSE American provides Acuren with greater visibility among institutional investors, hedge funds, and retail investors who prefer companies traded on major exchanges. This expanded exposure can contribute to a more diversified and stable shareholder base.
- Enhanced Liquidity: The transition to NYSE American is expected to significantly improve liquidity for Acuren’s stock, making it easier for investors to buy and sell shares. Increased liquidity can lead to a more accurate valuation of the company, benefiting both current and prospective shareholders.
- Greater Market Credibility: Listing on the NYSE American enhances Acuren’s corporate reputation. The stringent listing requirements and regulatory oversight associated with NYSE exchanges provide additional assurance to investors regarding the company’s financial health and operational transparency.
- Potential for Future Growth and Expansion: The listing aligns with Acuren’s broader growth strategy, enabling the company to pursue new opportunities for expansion, strategic acquisitions, and continued innovation within the TIC sector.
About Acuren Corporation
Acuren is a premier provider of critical asset integrity services, catering to a broad range of industrial markets across North America. The company is dedicated to delivering high-quality, compliance-driven services that ensure the safety, reliability, and efficiency of its clients’ infrastructure. Acuren’s work primarily falls under the Testing, Inspection, and Certification (TIC) sector, encompassing a variety of specialized services, including:
- Nondestructive Testing (NDT): Comprehensive field and laboratory-based inspections designed to evaluate the integrity of materials and structures without causing damage.
- Destructive Testing: Laboratory testing services that assess material properties through controlled damage testing.
- Advanced Inspection Techniques: Utilizing cutting-edge technologies such as ultrasonic testing, radiographic testing, and infrared thermography to identify defects and assess structural health.
- Engineering & Condition Monitoring: Services aimed at monitoring the long-term performance and maintenance needs of industrial assets.
- Pipeline Integrity Management: Ensuring the safety and regulatory compliance of pipeline infrastructure through rigorous inspections and testing.
Acuren operates in various industries, including oil and gas, power generation, aerospace, manufacturing, and infrastructure. Its ability to provide customized, high-quality solutions to clients has solidified its reputation as a leader in asset integrity and reliability services.
Commitment to Innovation and Growth
Acuren continues to invest in technological advancements and process improvements to enhance its service offerings. By leveraging innovations in artificial intelligence, machine learning, and data analytics, the company aims to drive efficiency and accuracy in its inspection processes. This commitment to innovation, combined with a strong focus on customer service, has positioned Acuren as a trusted partner for industrial clients seeking reliable and cost-effective asset integrity solutions.
As the company moves forward with its NYSE American listing, it remains focused on executing its strategic initiatives, strengthening its competitive advantage, and delivering value to shareholders. Acuren’s leadership believes that the transition to a major exchange will provide new opportunities for growth, enhance market confidence, and solidify its position as a leading player in the TIC industry.
Investor Information and Next Steps
For investors seeking more information about Acuren’s listing transition, the company has provided key details regarding the timeline:
- Final OTCQX Trading Day: February 14, 2025
- NYSE American Trading Start Date: February 18, 2025
- New Ticker Symbol: TIC
Investors are encouraged to visit Acuren’s official website at www.acuren.com for further updates, investor relations materials, and financial reports.
Acuren Corporation’s approval for listing on the NYSE American represents a major step forward in its growth journey. The transition is expected to provide increased market exposure, improved trading liquidity, and enhanced credibility within the financial community. With a strong leadership team, a commitment to innovation, and a clear strategic vision, Acuren is well-positioned to capitalize on new opportunities and deliver long-term value for its shareholders.
As the company prepares to commence trading on the NYSE American, it remains focused on strengthening its operational capabilities, expanding its market reach, and continuing to provide world-class asset integrity services to its customers across North America. This latest achievement underscores Acuren’s unwavering commitment to excellence, growth, and long-term success in the TIC industry.
